These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 17257446

  • 1. Behaviour and transit of tamsulosin Oral Controlled Absorption System in the gastrointestinal tract.
    Stevens HN, Speakman M.
    Curr Med Res Opin; 2006 Dec; 22(12):2323-8. PubMed ID: 17257446
    [Abstract] [Full Text] [Related]

  • 2. Pharmacoscintigraphy confirms consistent tamsulosin release from a novel triple-layered tablet.
    Hodges LA, Sime KA, Creech LA, Connolly SM, Barclay ST, Kwon MC, Jeon BJ, Shim SM, Wang HS, Stevens HN, Park JS.
    Int J Pharm; 2013 Sep 15; 454(1):41-6. PubMed ID: 23834829
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of the cardiovascular effects of tamsulosin oral controlled absorption system (OCAS) and alfuzosin prolonged release (XL).
    Michel MC, Chapple CR.
    Eur Urol; 2006 Mar 15; 49(3):501-8; discussion 508-9. PubMed ID: 16442211
    [Abstract] [Full Text] [Related]

  • 5. Analysis of small intestinal transit and colon arrival times of non-disintegrating tablets administered in the fasted state.
    Pišlar M, Brelih H, Mrhar A, Bogataj M.
    Eur J Pharm Sci; 2015 Jul 30; 75():131-41. PubMed ID: 25769525
    [Abstract] [Full Text] [Related]

  • 6. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA, Villalpando-Hernández J, Novoa-Heckel G, Oliva I, Cariño L, López-Bojórquez E, Burke-Fraga V, Namur S, González-de la Parra M.
    Clin Ther; 2009 Feb 30; 31(2):399-410. PubMed ID: 19302912
    [Abstract] [Full Text] [Related]

  • 7. Oral controlled-release morphine and gut function: a study in volunteers.
    Clyburn PA, Rosen M.
    Eur J Anaesthesiol; 1989 Sep 30; 6(5):347-53. PubMed ID: 2676529
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA, Tamimi JJ, Salem II, Ibrahim H, Sallam AA.
    Clin Ther; 2008 Oct 30; 30(10):1831-43. PubMed ID: 19014838
    [Abstract] [Full Text] [Related]

  • 10. A randomized double-blind placebo-controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder syndrome.
    Robinson D, Cardozo L, Terpstra G, Bolodeoku J, Tamsulosin Study Group.
    BJU Int; 2007 Oct 30; 100(4):840-5. PubMed ID: 17822465
    [Abstract] [Full Text] [Related]

  • 11. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA, Absalón-Reyes JA, Novoa-Heckel G, de Lago A, Oliva I, Rodríguez Z, González-de la Parra M, Burke-Fraga V, Namur S.
    Clin Ther; 2007 Jun 30; 29(6):1146-52. PubMed ID: 17692728
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Deposition and gastrointestinal transit of conventional sucralfate tablets.
    Vidgren M, Paronen P, Bergström K, Vainio P, Pikkarainen P.
    Acta Pharm Nord; 1991 Jun 30; 3(2):83-6. PubMed ID: 1910551
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
    Henney HR, Shah J.
    Clin Ther; 2007 Apr 30; 29(4):661-9. PubMed ID: 17617289
    [Abstract] [Full Text] [Related]

  • 16. Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects.
    Marier JF, Ducharme MP, DiMarco M, Di Spirito M, Morelli G, Tippabhotla SK, Badri N, Rampal A, Monif T.
    Clin Ther; 2006 Dec 30; 28(12):2070-80. PubMed ID: 17296463
    [Abstract] [Full Text] [Related]

  • 17. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
    Wonnemann M, Schug B, Anschütz M, Brendel E, De Nucci G, Blume H.
    Clin Ther; 2008 Jan 30; 30(1):48-58. PubMed ID: 18343242
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK, Cheng G, Tang J, Song J, Peng WX.
    Clin Ther; 2009 May 30; 31(5):1022-36. PubMed ID: 19539103
    [Abstract] [Full Text] [Related]

  • 19. Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: results of two randomized studies in patients with Parkinson's disease.
    Tompson DJ, Vearer D.
    Clin Ther; 2007 Dec 30; 29(12):2654-66. PubMed ID: 18201581
    [Abstract] [Full Text] [Related]

  • 20. Absorption of rivastigmine from different regions of the gastrointestinal tract in humans.
    Lee L, Hossain M, Wang Y, Sedek G.
    J Clin Pharmacol; 2004 Jun 30; 44(6):599-604. PubMed ID: 15145967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.